Legal Representation
Attorney
Martin Savitzky
USPTO Deadlines
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 2, 2005 | I | PAPER RECEIVED | Loading... | |
| May 9, 2005 | I | PAPER RECEIVED | Loading... | |
| Aug 2, 2005 | I | PAPER RECEIVED | Loading... | |
| May 9, 2005 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 9, 2005 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Aug 3, 2004 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Jul 15, 2004 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Jul 15, 2004 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 17, 2004 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Apr 26, 2004 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 3, 2004 | FAXX | I | FAX RECEIVED | Loading... |
| Jan 20, 2004 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 22, 2002 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 2, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jul 29, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 3, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 21, 2002 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 18, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 18, 2002 | I | PAPER RECEIVED | Loading... | |
| Sep 27, 2001 | CNRT | O | NON-FINAL ACTION MAILED | Loading... |
| Jul 2, 2001 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 14, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Feb 12, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 6, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
(Based on 44(e)) nucleic acid arrays on chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases; chemical reagents for medical use
First Use Anywhere:
0
First Use in Commerce:
0
Class 009
(Based on 44(e)) Computer programs for medical testing, to analyze nucleic acids present in human or animal cells, using nucleic acid arrays on chips and chemical reagents, to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
(Based on 44(e)) nucleic acid probes on chips for use in medical research and medical tests permitting the analysis of nucleic acids present in human or animal cells to determine the effect of drugs on pathologies, namely, cancer and neurodegenerative diseases, and/or the characteristics of such pathologies, namely, cancer and neurodegenerative diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
(Based on Intent to Use) (Based on 44(e)) Medical testing services for analysis of nucleic acids found in human or animal cells to determine the presence of pathologies, namely, cancer and neurodegenerative diseases, or the effect of drugs on such pathologies, namely, cancer and neurodegenerative diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
009
010
042